跳至主要内容
临床试验/NCT02384187
NCT02384187已完成3 期

The Effects of Oral Gabapentin Premedication on Postoperative Nausea and Vomiting and Early Postoperative Recovery Profile in Pediatric Patients Undergoing Adenotonsillectomy

Cairo University1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2015年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
140
试验地点
1
主要终点
Incidence of PONV

研究概览

简要总结

The frequent incidence of postoperative vomiting and severe pain in children undergoing adenotonsillectomy, may delay postoperative oral intake and increase the risk of dehydration. Postoperative nausea and vomiting (PONV) is of multi-factorial origin in this group of patients, with a reported incidence ranging from 23% to 73%.

There is growing evidence that the perioperative administration of gabapentinin in adults is beneficial for preoperative anxiolysis, postoperative analgesia, reduction of postoperative nausea and vomiting, and delirium.

Only few studies in literature explored the analgesic effects of preoperative gabapentin as premedication in pediatric population. However, the antiemetic effect of gabapentin in pediatric patients was not systematically investigated before.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Aged (3-12)
  • ASA physical status I or II
  • Scheduled for adenotonsillectomy surgery in Abu Elrish Al-Mounira Hospital

排除标准

  • Patients who have active infection
  • Obstructive sleep apnea
  • Cognitive impairment
  • Abnormal bleeding profile
  • Renal or hepatic dysfunction
  • History of allergic reaction to study medications or chronic use of anti-consultants will be excluded.

研究组 & 干预措施

Group C

Placebo Comparator

Patients in this group will receive 0.3 ml/kg of a placebo solution identical in taste, shape and color to the study medication two hours before the induction of anesthesia.

干预措施: placebo (Drug)

Group GAB

Experimental

Patients in this group will receive 0.3 ml/kg (16 mg/kg) oral gabapentin solution (Neurontin 50 mg/ml, Pfizer Pharmaceutical) as premedication two hours before the induction of anesthesia

干预措施: Gabapentin as premedication (Drug)

结局指标

主要结局

Incidence of PONV

时间窗: over the first postoperative 6 hours

The number of patient complaints of nausea and or vomiting will be recorded in the first 6 hours postoperatively

次要结局

  • Time to first request of postoperative rescue analgesics.(over the first postoperative 6 hours)
  • Duration of recovery(up to 60 minutes after the end of surgery.)
  • Postoperative analgesic consumption(over the first postoperative 6 hours)
  • Objective pain scale (OPS)(over the first postoperative 6 hours)
  • Pediatric Anesthesia Behavior score (PAB)(within10 minutes before the child falls asleep.)
  • Incidence and severity of postoperative delirium(up to 60 minutes after the end of the operation.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

heba mohamed nassar

lecturer of anesthesia

Cairo University

研究点 (1)

Loading locations...

相似试验